tiprankstipranks
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
OKUR
OnKure Therapeutics
RESEARCH TOOLSreports

OnKure Therapeutics (OKUR) Financial Statements

Compare
433 Followers

OnKure Therapeutics Financial Overview

OnKure Therapeutics's market cap is currently $54.56M. The company's EPS TTM is $-0.99; its P/E ratio is -0.66; OnKure Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -830.00K$ 0.00$ 0.00$ 0.00$ -50.00K
Operating Income$ -62.95M$ -54.39M$ -36.93M$ -29.77M$ -39.82M
EBITDA$ -62.12M$ -51.71M$ -34.75M$ -29.38M$ -39.72M
Net Income$ -59.52M$ -52.67M$ -35.31M$ -29.51M$ -39.77M
Balance Sheet
Cash & Short-Term Investments$ 59.05M$ 110.76M$ 29.88M$ 11.54M$ 147.67M
Total Assets$ 62.12M$ 114.91M$ 35.73M$ 16.00M$ 154.02M
Total Debt$ 549.00K$ 1.08M$ 674.00K$ 637.00K$ 0.00
Net Debt$ -58.50M$ -109.68M$ -29.20M$ -10.91M$ -124.66M
Total Liabilities$ 5.93M$ 11.08M$ 137.58M$ 70.42M$ 6.81M
Stockholders' Equity$ 56.18M$ 103.83M$ -101.84M$ -54.42M$ 147.21M
Cash Flow
Free Cash Flow$ -51.87M$ -51.17M$ -34.79M$ -28.09M$ -38.18M
Operating Cash Flow$ -51.83M$ -51.12M$ -34.55M$ -26.95M$ -37.98M
Investing Cash Flow$ -46.00K$ 15.87M$ -246.00K$ -1.13M$ -23.38M
Financing Cash Flow$ 163.00K$ 116.13M$ 53.13M$ 26.46M$ 132.41M
Currency in USD

OnKure Therapeutics Earnings and Revenue History

Income Statement >

OnKure Therapeutics Debt to Assets

Balance Sheet >

OnKure Therapeutics Cash Flow

Cash Flow >

OnKure Therapeutics Forecast EPS vs Actual EPS

Earnings >